FDA WARNING_LETTER - Mc-NEIL-PPC, Inc. - January 19, 2012
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On December 12, 2011, through January 19, 2012, an FDA inspection of McNeil-PPC, Inc. in Skillman, New Jersey, identified significant violations of the Quality System regulation (21 CFR Part 820) for various devices including K-Y products, Visine for Contacts, O.B. Tampons, Reach Floss, and Stayfree/Carefree menstrual napkins. The inspection found these devices adulterated under section 501(h) of the Act due to non-conformity with good manufacturing practices.
Key violations include: 1. **Failure to establish and maintain adequate complaint files and procedures (21 CFR 820.198(a))**: Numerous K-Y Liquibeads complaints, including medical complaints and those with specific subject codes, were not adequately evaluated, investigated, or justified, and some were closed based on invalid lot number assumptions. 2. **Failure to promptly review and investigate MDR reportable complaints (21 CFR 820.198(d))**: Complaint investigation procedures were not effectively implemented, leading to incomplete investigations and failure to meet review timeframes for 9 out of 19 MDR reportable complaints. This was a repeat deficiency from a 2009 inspection. 3. **Failure to establish and maintain adequate procedures for validating device design (21 CFR 8
ID · d7a92e0b-aefa-4d50-8c19-7e9a69408dbd
Full citation text and observation details available on the Dashboard.